Used in research as a potent and selective inhibitor of protein arginine methyltransferase 1 (PRMT1), an enzyme involved in epigenetic regulation. It modulates cellular methylation processes, making it valuable in studying cancer biology, particularly in leukemia and other hematological malignancies. Shows potential as a lead compound for developing anticancer agents due to its ability to induce cell cycle arrest and apoptosis in tumor cells. Also employed in biochemical assays to probe the role of PRMT1 in signal transduction and gene expression.